Copyright © Inderes 2011 - present. All rights reserved.

CellaVision

164

 

SEK

 

-0.24 %

1,489 following

CEVI

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Compare
-0.24%
-15.46%
-24.6%
-27.11%
-39.59%
-31.38%
-47.67%
-28.07%
+951.28%

CellaVision operates in the medical technology industry and focuses on the development and manufacture of systems for digital blood analysis. The company's products are aimed at healthcare institutions and laboratories. The business is global, with a primary presence in Europe, North America and Asia. CellaVision was founded in 1994 and is headquartered in Lund, Sweden.

Read more
Market cap
3.91B SEK
Turnover
3.67M SEK
Revenue
723.22M
EBIT %
24.57 %
P/E
27.8
Dividend yield-%
1.37 %
Financial calendar
29.4
2025

Interim report Q1'25

6.5
2025

General meeting '25

7.5
2025

Annual dividend

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.